Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I know a sale when i see one :-) Keep the faith

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Dec 17, 2023 12:53pm

304 Views

Post# 35788829

RE:I know a sale when i see one :-) Keep the faith

The value of the patent Theralase holds on Ruthenium and TLD1433 is becoming more apparent on a global scale. Once FDA approves it for BTD and AA the multi indication use will be huge. Market Cap will start with a B and who knows how many multiples. Just IMO.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments